AllInfo

Malaria vaccination: What you can and cannot do

The first Malaria vaccine offers only partial protection. However, any other immunization that may change soon. Researchers are optimistic.

A boy at CERMEL in Gabon is removed in the context of a Malaria-study blood.

What is the current Malaria vaccination?

In a pilot experiment for this week is the first Malaria vaccine ‘RTS,S will be tested in a vaccination campaign in Malawi. In Ghana and Kenya it is supposed to start in the coming week. But Malaria researchers are not yet satisfied: “RTS,S, the is Best what we have so far developed, it shows a vaccine is possible but the efficacy is simply not good enough,” says Prof. Peter Kremsner, Director of the Institute for tropical medicine of the University of Tübingen.

Because of three decades of developed vaccine ‘RTS,S’ prevented in previous studies, barely a third of the Malaria-diseases of the WHO, 75 per cent or more would be desired. In addition, the protective effect within a period of four years.

The reason is that the ‘RTS to bring S’ vaccine uses a single Protein of the most common in Africa,occurring Malaria pathogen Plasmodium falciparum, the immune system against the parasite in position. However, an immune response to a Protein of the pathogen also means that the immune system again and again, invaders miss and it comes to Malaria. In addition, there are in addition to the Plasmodium falciparum other Malaria pathogen, against which the ‘RTS,S’ is not effective vaccination.

More: World’s biggest vaccination campaign against Malaria start in Africa

Prof. Peter Kremsner with a colleague in Gabon

Why you need a vaccination?

Still, thousands of people die each year from Malaria. 435,000 people there were in the world in the year 2017. The majority of them children under five years of age. Over 90 percent of the death cases recorded on the African continent. And after the malaria case numbers were long in decline, have increased, according to the world health organization (WHO) in the last two years. “It seems we’ve maxed the previous methods for Malaria containment. The tools we can use today, seem to be able to no further reduction in the number of cases”, presumed to be of tropical medicine Prof. Benjamin murder müller of the University of Tübingen. Thus, the pressure to develop an effective vaccine increases.

What is failed to be an effective Malaria vaccine so far?

The Malaria pathogen is a parasite and not a bacterium or a Virus like many other infectious diseases. This parasite is living through a complex cycle with different life stages, both in mosquitoes and in humans. Therefore, it was to teach is particularly difficult for the human immune system with a vaccination, as it can detect the Malaria parasites and fought.

“The science has 50 years of single-surface structures in the Malaria parasite attempts to isolate so – called antigens for vaccination. All potential vaccine candidates, however, have failed”, explains Prof. Kremsner.

More: dogs detect Malaria at the smell of socks

Malaria mosquito of the genus Anopheles gambiae

At the Institute for tropical medicine in Tübingen, scientists have now opted for a different approach – a live vaccine, in which the real causative agent is injected. “In the past, it was with such a complex pathogen such as the Malaria is not possible,” says Prof. murder müller, who is involved in the research project.

With the support of the Biotech company Sanaria in the United States, the researchers succeeded in mosquitoes occurring Form of the Malaria parasite called sporozoites to breed in the laboratory in large quantities. These sporozoites are frozen and are the Basis for the new live vaccine.


How does this new vaccination?

The new of the tübingen researchers vaccine, co-developed the sporozoites with the radio attenuated radiation before injecting them as a vaccine. The result: the Malaria pathogen lives long enough in the human body, to produce a reaction of the immune system, dies, but before he can make the injected sick people. In Tübingen, this new Form of Malaria, was tested in vaccination in healthy Europeans successfully. “With very high efficiencies,” promises Prof. Kremsner. The advantage compared to the “RTS,S”vaccine: the immune system now reacts to all the parasites, not on a single Protein and, thus, the effectiveness increases.

Who could protect the new vaccine?

As a vaccination for travelers in Malaria-‘m going to give areas the new vaccine in a few years, since Prof. Kremsner is sure. Whether the effectiveness in Africa, similar, will show up at the end of this year, when there were the first results from an ongoing Phase II study in children in Gabon. “At the Moment it looks everything very well. I would have said, ‘RTS, S’ never,” says the tropical medicine Kremsner, who was also involved in the authorisation of ‘RTS,S’.

More: Is Malaria, with Gene Drive to completely eradicate?


Exit mobile version